Skip to main content

The Debate against Elective Lymph Node Dissection in Papillary Thyroid Carcinoma

  • Chapter
  • First Online:
  • 780 Accesses

Abstract

In this chapter we set out the debate against elective neck dissection for differentiated thyroid cancer. We critically analyze the arguments that this practice results in improved survival and reduced rates of recurrence and prevents complications from avoiding future salvage surgery and that it streamlines treatment by selecting those patients most likely to benefit from adjuvant therapy. We go on to consider the morbidity of the procedure in the hands of the majority of surgeons who treat differentiated thyroid cancer and discuss the indolent biology of occult metastases during observation. We highlight the cost arguments against elective neck dissection and describe in detail the incidence and operative findings in salvage surgery which refute the claims that prophylactic surgery prevents future morbidity. The accepted calculation which shows that oncological benefit will never be proven statistically means that the clinical significance of increased morbidity and cost will always outweigh any marginal oncological benefit derived. We conclude that elective neck surgery cannot be justified in differentiated thyroid cancer, especially in low-risk patients.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Abbreviations

ATA:

American Thyroid Association

DTC:

Differentiated thyroid cancer

ECND:

Elective central neck dissection

ELND:

Elective lateral neck dissection

END:

Elective neck dissection

PTC:

Papillary thyroid cancer

RAI:

Radioactive iodine

Tg:

Thyroglobulin

References

  1. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006;295(18):2164–7. PubMed PMID: 16684987. Epub 2006/05/11. eng.

    Article  CAS  PubMed  Google Scholar 

  2. Enewold L, Zhu K, Ron E, Marrogi AJ, Stojadinovic A, Peoples GE, et al. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomark Prev. 2009;18(3):784–91. PubMed PMID: 19240234. Pubmed Central PMCID: 2676561. Epub 2009/02/26. eng.

    Article  Google Scholar 

  3. Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer. 2009;115(16):3801–7. PubMed PMID: 19598221. Epub 2009/07/15. eng.

    Article  PubMed  Google Scholar 

  4. Kilfoy BA, Zheng T, Holford TR, Han X, Ward MH, Sjodin A, et al. International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control. 2009;20(5):525–31. PubMed PMID: 19016336. Pubmed Central PMCID: 2788231.

    Article  PubMed  Google Scholar 

  5. Cramer JD, Fu P, Harth KC, Margevicius S, Wilhelm SM. Analysis of the rising incidence of thyroid cancer using the Surveillance, Epidemiology and End Results national cancer data registry. Surgery. 2010;148(6):1147–52. Discussion 52–3. PubMed PMID: 21134545. Epub 2010/12/08. eng.

    Article  PubMed  Google Scholar 

  6. Olaleye O, Ekrikpo U, Moorthy R, Lyne O, Wiseberg J, Black M, et al. Increasing incidence of differentiated thyroid cancer in South East England: 1987-2006. Eur Arch Otorhinolaryngol. 2011;268(6):899–906. PubMed PMID: 21072529. Epub 2010/11/13. eng.

    Article  PubMed  Google Scholar 

  7. Aschebrook-Kilfoy B, Ward MH, Sabra MM, Devesa SS. Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006. Thyroid. 2011;21(2):125–34. PubMed PMID: 21186939. Pubmed Central PMCID: 3025182.

    Article  PubMed  PubMed Central  Google Scholar 

  8. McNally RJ, Blakey K, James PW, Gomez Pozo B, Basta NO, Hale J. Increasing incidence of thyroid cancer in Great Britain, 1976-2005: age-period-cohort analysis. Eur J Epidemiol. 2012;27(8):615–22. PubMed PMID: 22760704.

    Article  PubMed  Google Scholar 

  9. Li N, Du XL, Reitzel LR, Xu L, Sturgis EM. Impact of enhanced detection on the increase in thyroid cancer incidence in the United States: review of incidence trends by socioeconomic status within the surveillance, epidemiology, and end results registry, 1980-2008. Thyroid. 2013;23(1):103–10. PubMed PMID: 23043274. Pubmed Central PMCID: 3539256.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Finlayson A, Barnes I, Sayeed S, McIver B, Beral V, Ali R. Incidence of thyroid cancer in England by ethnic group, 2001-2007. Br J Cancer. 2014;110(5):1322–7. PubMed PMID: 24448361. Pubmed Central PMCID: 3950880.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Carty SE, Cooper DS, Doherty GM, Duh QY, Kloos RT, Mandel SJ, et al. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid. 2009;19(11):1153–8. PubMed PMID: 19860578. Epub 2009/10/29. eng.

    Article  PubMed  Google Scholar 

  12. Ferris R, Goldenberg D, Haymart MR, Shaha AR, Seth S, Sosa JA, et al. American Thyroid Association consensus review of the anatomy, terminology and rationale for lateral neck dissection in differentiated thyroid cancer. Thyroid. 2012. PubMed PMID: 22247974. Epub 2012/01/18. Eng.

    Google Scholar 

  13. Hartl DM, Leboulleux S, Al Ghuzlan A, Baudin E, Chami L, Schlumberger M, et al. Optimization of staging of the neck with prophylactic central and lateral neck dissection for papillary thyroid carcinoma. Ann Surg. 2012;255(4):777–83. PubMed PMID: 22418010.

    Article  PubMed  Google Scholar 

  14. Polistena A, Monacelli M, Lucchini R, Triola R, Conti C, Avenia S, et al. Surgical morbidity of cervical lymphadenectomy for thyroid cancer: a retrospective cohort study over 25 years. Int J Surg. 2015;21:128–34. PubMed PMID: 26253851.

    Article  PubMed  Google Scholar 

  15. Shaha AR. Complications of neck dissection for thyroid cancer. Ann Surg Oncol. 2008;15(2):397–9. PubMed PMID: 18058179. Pubmed Central PMCID: 2244697. Epub 2007/12/07. eng.

    Article  PubMed  Google Scholar 

  16. Roh JL, Kim DH, Park CI. Prospective identification of chyle leakage in patients undergoing lateral neck dissection for metastatic thyroid cancer. Ann Surg Oncol. 2008;15(2):424–9. PubMed PMID: 17999116.

    Article  PubMed  Google Scholar 

  17. Roh JL, Park JY, Park CI. Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone. Ann Surg. 2007;245(4):604–10. PubMed PMID: 17414610. Pubmed Central PMCID: 1877043.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Cheah WK, Arici C, Ituarte PH, Siperstein AE, Duh QY, Clark OH. Complications of neck dissection for thyroid cancer. World J Surg. 2002;26(8):1013–6. PubMed PMID: 12045861.

    Article  PubMed  Google Scholar 

  19. Meissner WA, Colcock BP, Achenbach H. The pathologic evaluation of radical neck dissection for carcinoma of the thyroid gland. J Clin Endocrinol Metab. 1955;15(11):1432–6. PubMed PMID: 13271527.

    Article  CAS  PubMed  Google Scholar 

  20. Tollefsen HR, Decross JJ. Papillary carcinoma of the thyroid. The case for radical neck dissection. Am J Surg. 1964;108:547–51. PubMed PMID: 14211446. Epub 1964/10/01. eng.

    Article  CAS  PubMed  Google Scholar 

  21. Hutter RV, Frazell EL, Foote Jr FW. Elective radical neck dissection: an assessment of its use in the management of papillary thyroid cancer. CA Cancer J Clin. 1970;20(2):87–93. PubMed PMID: 4987868.

    Article  CAS  PubMed  Google Scholar 

  22. Dargent M. Thyroidectomy with block dissection of the neck for carcinoma of the thyroid gland. Lancet. 1948;2(6532):721–3. PubMed PMID: 18894185.

    Article  CAS  PubMed  Google Scholar 

  23. Haugen BRM, Alexander EK, Bible KC, Doherty G, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133. PubMed PMID: 26462967.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Perros P, Boelaert K, Colley S, Evans C, Evans RM, Gerrard Ba G, et al. Guidelines for the management of thyroid cancer. Clin Endocrinol. 2014;81(Suppl 1):1–122. PubMed PMID: 24989897.

    Article  CAS  Google Scholar 

  25. Hwang HS, Orloff LA. Efficacy of preoperative neck ultrasound in the detection of cervical lymph node metastasis from thyroid cancer. Laryngoscope. 2011;121(3):487–91. PubMed PMID: 21344423.

    Article  PubMed  Google Scholar 

  26. Nixon IJ, Wang LY, Ganly I, Patel SG, Morris LG, Migliacci JC, et al. Outcomes for patients with papillary thyroid cancer who do not undergo prophylactic central neck dissection. Br J Surg. 2016;103(3):218–25. PubMed PMID: 26511531. Epub 2015/10/30. Eng.

    Article  CAS  PubMed  Google Scholar 

  27. Nixon IJ, Ganly I, Patel SG, Morris LG, Palmer FL, Thomas D, et al. Observation of clinically negative central compartment lymph nodes in papillary thyroid carcinoma. Surgery. 2013;154(6):1166–72. Discussion 72–3. PubMed PMID: 24238042.

    Article  PubMed  Google Scholar 

  28. Urken ML, Milas M, Randolph GW, Tufano R, Bergman D, Bernet V, et al. A review of the management of recurrent and persistent metastatic lymph nodes in well differentiated thyroid cancer: a multifactorial decision making guide created for the Thyroid Cancer Care Collaborative. Head Neck. 2014;17. PubMed PMID: 24436291.

    Google Scholar 

  29. Steward DL. Update in utility of secondary node dissection for papillary thyroid cancer. J Clin Endocrinol Metab. 2012;97(10):3393–8. PubMed PMID: 22791761.

    Article  PubMed  Google Scholar 

  30. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471–4. PubMed PMID: 20180029. Epub 2010/02/25. eng.

    Article  PubMed  Google Scholar 

  31. Hay ID, Thompson GB, Grant CS, Bergstralh EJ, Dvorak CE, Gorman CA, et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg. 2002;26(8):879–85. PubMed PMID: 12016468. Epub 2002/05/23. eng.

    Article  PubMed  Google Scholar 

  32. Nixon IJ, Ganly I, Patel SG, Palmer FL, Whitcher MM, Ghossein R, et al. Changing trends in well differentiated thyroid carcinoma over eight decades. Int J Surg. 2012;367(8):705–15. PubMed PMID: 23128246.

    Google Scholar 

  33. Sywak M, Cornford L, Roach P, Stalberg P, Sidhu S, Delbridge L. Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery. 2006;140(6):1000–5. Discussion 5–7. PubMed PMID: 17188149.

    Article  PubMed  Google Scholar 

  34. Popadich A, Levin O, Lee JC, Smooke-Praw S, Ro K, Fazel M, et al. A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer. Surgery. 2011;150(6):1048–57. PubMed PMID: 22136820.

    Article  PubMed  Google Scholar 

  35. Monchik JM, Simon CJ, Caragacianu DL, Thomay AA, Tsai V, Cohen J, et al. Does failure to perform prophylactic level VI node dissection leave persistent disease detectable by ultrasonography in patients with low-risk papillary carcinoma of the thyroid? Surgery. 2009;146(6):1182–7. PubMed PMID: 19958947. Epub 2009/12/05. eng.

    Article  PubMed  Google Scholar 

  36. Zetoune T, Keutgen X, Buitrago D, Aldailami H, Shao H, Mazumdar M, et al. Prophylactic central neck dissection and local recurrence in papillary thyroid cancer: a meta-analysis. Ann Surg Oncol. 2010;17(12):3287–93. PubMed PMID: 20596784.

    Article  PubMed  Google Scholar 

  37. Chadwick D, Kinsman R, Walton P. The British Association of Endocrine & Thyroid Surgeons fourth national audit report. Oxfordshire: Dendrite Clinical Systems Ltd; 2012.

    Google Scholar 

  38. Chisholm EJ, Kulinskaya E, Tolley NS. Systematic review and meta-analysis of the adverse effects of thyroidectomy combined with central neck dissection as compared with thyroidectomy alone. Laryngoscope. 2009;119(6):1135–9. PubMed PMID: 19358241. Epub 2009/04/10. eng.

    Article  PubMed  Google Scholar 

  39. Bonnet S, Hartl D, Leboulleux S, Baudin E, Lumbroso JD, Al Ghuzlan A, et al. Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment. J Clin Endocrinol Metab. 2009;94(4):1162–7. PubMed PMID: 19116234. Epub 2009/01/01. eng.

    Article  CAS  PubMed  Google Scholar 

  40. Sancho JJ, Lennard TW, Paunovic I, Triponez F, Sitges-Serra A. Prophylactic central neck disection in papillary thyroid cancer: a consensus report of the European Society of Endocrine Surgeons (ESES). Langenbeck’s Arch Surg. 2014;399(2):155–63. PubMed PMID: 24352594. Epub 2013/12/20. eng.

    Article  Google Scholar 

  41. Ahn D, Sohn JH, Park JY. Surgical complications and recurrence after central neck dissection in cN0 papillary thyroid carcinoma. Auris Nasus Larynx. 2014;41(1):63–8. PubMed PMID: 23886706. Epub 2013/07/28. eng.

    Article  PubMed  Google Scholar 

  42. Giordano D, Valcavi R, Thompson GB, Pedroni C, Renna L, Gradoni P, et al. Complications of central neck dissection in patients with papillary thyroid carcinoma: results of a study on 1087 patients and review of the literature. Thyroid. 2012;22(9):911–7. PubMed PMID: 22827494.

    Article  PubMed  Google Scholar 

  43. Ywata de Carvalho A, Chulam TC, Kowalski LP. Long-term results of observation vs prophylactic selective level VI neck dissection for papillary thyroid carcinoma at a cancer center. JAMA Otolaryngol Head Neck Surg. 2015;141(7):599–606. PubMed PMID: 25997016.

    Article  PubMed  Google Scholar 

  44. Wang TS, Evans DB, Fareau GG, Carroll T, Yen TW. Effect of prophylactic central compartment neck dissection on serum thyroglobulin and recommendations for adjuvant radioactive iodine in patients with differentiated thyroid cancer. Ann Surg Oncol. 2012;19(13):4217–22. PubMed PMID: 23010732.

    Article  PubMed  Google Scholar 

  45. Laird AM, Gauger PG, Miller BS, Doherty GM. Evaluation of postoperative radioactive iodine scans in patients who underwent prophylactic central lymph node dissection. World J Surg. 2012;36(6):1268–73. PubMed PMID: 22270997.

    Article  PubMed  Google Scholar 

  46. Mulla MG, Knoefel WT, Gilbert J, McGregor A, Schulte KM. Lateral cervical lymph node metastases in papillary thyroid cancer: a systematic review of imaging-guided and prophylactic removal of the lateral compartment. Clin Endocrinol. 2012;77(1):126–31. PubMed PMID: 22233478.

    Article  Google Scholar 

  47. Bozec A, Dassonville O, Chamorey E, Poissonnet G, Sudaka A, Peyrottes I, et al. Clinical impact of cervical lymph node involvement and central neck dissection in patients with papillary thyroid carcinoma: a retrospective analysis of 368 cases. Eur Arch Otorhinolaryngol. 2011;268(8):1205–12. PubMed PMID: 21607578. Epub 2011/05/25. eng.

    Article  PubMed  Google Scholar 

  48. Pereira JA, Jimeno J, Miquel J, Iglesias M, Munne A, Sancho JJ, et al. Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma. Surgery. 2005;138(6):1095–100. Discussion 100–1. PubMed PMID: 16360396. Epub 2005/12/20. eng.

    Article  PubMed  Google Scholar 

  49. Barczynski M, Konturek A, Stopa M, Nowak W. Prophylactic central neck dissection for papillary thyroid cancer. Br J Surg. 2013;100(3):410–8. PubMed PMID: 23188784.

    Article  CAS  PubMed  Google Scholar 

  50. Youngwirth LM, Adam MA, Scheri RP, Roman SA, Sosa JA. Patients treated at low-volume centers have higher rates of incomplete resection and compromised outcomes: analysis of 31,129 patients with papillary thyroid cancer. Ann Surg Oncol. 2016;23(2):403–9. PubMed PMID: 26416710.

    Article  PubMed  Google Scholar 

  51. Sosa JA, Bowman HM, Tielsch JM, Powe NR, Gordon TA, Udelsman R. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg. 1998;228(3):320–30. PubMed PMID: 9742915. Pubmed Central PMCID: 1191485.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Hauch A, Al-Qurayshi Z, Randolph G, Kandil E. Total thyroidectomy is associated with increased risk of complications for low- and high-volume surgeons. Ann Surg Oncol. 2014;21(12):3844–52. PubMed PMID: 24943236.

    Article  PubMed  Google Scholar 

  53. Nixon IJ, Shah JP. Well differentiated thyroid cancer: are we over treating our patients? Eur J Surg Oncol. 2014;40(2):129–32. PubMed PMID: 24373300.

    Article  CAS  PubMed  Google Scholar 

  54. Carling T, Carty SE, Ciarleglio MM, Cooper DS, Doherty G, Kim LT, et al. American Thyroid Association (ATA)—design and feasibility of a prospective randomized controlled trial of prophylactic central lymph node dissection for papillary thyroid carcinoma. Thyroid. 2011;9. PubMed PMID: 22150591. Epub 2011/12/14. Eng.

    Google Scholar 

  55. Zanocco K, Elaraj D, Sturgeon C. Routine prophylactic central neck dissection for low-risk papillary thyroid cancer: a cost-effectiveness analysis. Surgery. 2013;154(6):1148–55. Discussion 54–5. PubMed PMID: 24383082. Epub 2014/01/03. eng.

    Article  PubMed  Google Scholar 

  56. Sosa JA. Is routine prophylactic central neck dissection indicated for low-risk papillary thyroid cancer: can we determine cost-effectiveness if we are unsure about its effectiveness and safety? Surgery. 2013;154(6):1146–7. PubMed PMID: 24238040. Epub 2013/11/19. eng.

    Article  PubMed  Google Scholar 

  57. Pai SI, Tufano RP. Reoperation for recurrent/persistent well-differentiated thyroid cancer. Otolaryngol Clin N Am. 2010;43(2):353–63, ix. PubMed PMID: 20510718.

    Article  Google Scholar 

  58. Clayman GL, Agarwal G, Edeiken BS, Waguespack SG, Roberts DB, Sherman SI. Long-term outcome of comprehensive central compartment dissection in patients with recurrent/persistent papillary thyroid carcinoma. Thyroid. 2011;21(12):1309–16. PubMed PMID: 22136266.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167–214. PubMed PMID: 19860577. Epub 2009/10/29. eng.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Iain J. Nixon Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 The Author(s)

About this chapter

Cite this chapter

Nixon, I.J., Shaha, A.R. (2017). The Debate against Elective Lymph Node Dissection in Papillary Thyroid Carcinoma. In: Mancino, A., Kim, L. (eds) Management of Differentiated Thyroid Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-54493-9_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-54493-9_15

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-54492-2

  • Online ISBN: 978-3-319-54493-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics